Medical Care Technologies to include HVS as add-on to its Tele-Health Suite

Medical Care Technologies Inc. (OTCBB: MDCE) today announced that it has been developing its latest medical device technology -- Heart Vital Signs ("HVS") to be included as an add-on to its Tele-Health™ Suite. Remote cardiac monitoring technologies allow home electrocardiographic (ECG) monitoring of patients with suspected cardiac arrhythmias or at risk for developing arrhythmias.

Management believes that by adding the HVS function to its Tele-Health™ technology, caregivers will be able to monitor a patient's cardiac function, no matter where the patient is located. By using an embedded SIM card which connects to a cellular network, streaming signals are transmitted to a remote server whereby physicians or caregivers, through Tele-Health™ Suite, may access and monitor the patient's heart.

MDCE's HVS is simple and easy to use with non-invasive sensors attached to the skin for patient comfort and fast recognition of cardiac and respiratory readings. The HVS is a small, portable physiological monitor that includes a receiver which wirelessly receives the patient's physiological measurements.

According to the World Health Organization (2009 Update), cardiovascular failure is the leading cause of death in the world. In China, data sources suggest that there are between 1 million and 1.5 million stroke deaths per year, and approximately 600,000 more deaths from heart disease. Altogether, cardiovascular failure probably claims about 2.5 million lives -- or almost 30% of all deaths in China -- each year.

MDCE's President, Ning Wu, commented, "We are pleased with our team's efforts in searching for solutions to better care for and monitor a patient's heart. We believe that once our HVS technology is fully developed, physicians and caregivers alike will be able to provide the best possible remote monitoring for cardiology practices, hospitals and nursing homes, ambulatory electrocardiography and home-care services. We are hopeful that HVS will be available to the Chinese market in the near future."